Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate - Yahoo Finance

2026-01-27 - 10:48

Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate Yahoo Finance